Appointment of NOMAD

17th December 2018 - 12:26 pm


ImmuPharma PLC (LSE: IMM), the specialist drug discovery and development company is pleased to announce the appointment of SPARK Advisory Partners Limited (“SPARK”) as the Company’s Nominated Advisor (“NOMAD”), with immediate effect.

Commenting on the appointment, ImmuPharma’s Chairman, Tim McCarthy, said: “I am delighted to announce the appointment of SPARK as the Company’s NOMAD. We look forward to working with the team going forward, alongside our joint brokers, Stanford Capital Partners and SI Capital.”

Share this article